UB Paderborn / Katalog / Suche / in CDI

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

The Lancet infectious diseases, 2012-04, Vol.12 (4), p.307-317

2012

Link zum Volltext

Verfügbarkeit prüfen

Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa

Journal of antimicrobial chemotherapy, 2016-10, Vol.71 (10), p.2918-2927

2016

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

The Lancet infectious diseases, 2011-10, Vol.11 (10), p.750-759

2011

Link zum Volltext

Verfügbarkeit prüfen

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies

Clinical infectious diseases, 2012-06, Vol.54 (11), p.1660-1669

2012

Link zum Volltext

Verfügbarkeit prüfen

Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa

Journal of acquired immune deficiency syndromes (1999), 2011-09, Vol.58 (1), p.23

2011

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment HIV Drug Resistance Increases Regimen Switches in Sub-Saharan Africa

Clinical infectious diseases, 2015-12, Vol.61 (11), p.1749-1758

2015

Link zum Volltext

Verfügbarkeit prüfen

Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa

The Journal of infectious diseases, 2016-09, Vol.214 (6), p.873-883

2016

Link zum Volltext

Verfügbarkeit prüfen

HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes

Journal of acquired immune deficiency syndromes (1999), 2013-10, Vol.64 (2), p.174

2013

Link zum Volltext

Verfügbarkeit prüfen

Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa

The Journal of infectious diseases, 2012-06, Vol.205 (11), p.1739-1744

2012

Link zum Volltext

Verfügbarkeit prüfen

Using e-coins to ensure fair sharing of donor funds amongst HIV healthcare facilities

South African computer journal = Suid-Afrikaanse rekenaartydskrif, 2011-11, Vol.47 (47)

2011

Link zum Volltext

Verfügbarkeit prüfen

Early Warning Indicators for Population-Based Monitoring of HIV Drug Resistance in 6 African Countries

Clinical infectious diseases, 2012-05, Vol.54 (suppl_4), p.S294-S299, Article S294

2012

Link zum Volltext

Verfügbarkeit prüfen

Building Capacity for the Assessment of HIV Drug Resistance: Experiences From the PharmAccess African Studies to Evaluate Resistance Network

Clinical infectious diseases, 2012-05, Vol.54 (suppl 4), p.S261-S265

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study

The lancet HIV, 2018-11, Vol.5 (11), p.e638-e646

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial with oral oxihumate in HIV-infected patients

Drug development research, 2002-09, Vol.57 (1), p.34-39

2002

Link zum Volltext

Verfügbarkeit prüfen

Building Capacity for the Assessment of HIV Drug Resistance: Experiences From the PharmAccess African Studies to Evaluate Resistance Network: The World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: Global, Regional, and Country Progress

Clinical infectious diseases, 2012, Vol.54

2012

Link zum Volltext

Verfügbarkeit prüfen

Using e-coins to ensure fair sharing of donor funds amongst HIV healthcare facilities : research article

South African computer journal = Suid-Afrikaanse rekenaartydskrif, 2011-07, Vol.47 (1), p.47-57

2011

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies

Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa

Pretreatment HIV Drug Resistance Increases Regimen Switches in Sub-Saharan Africa

Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa

HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes

Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa

Using e-coins to ensure fair sharing of donor funds amongst HIV healthcare facilities

Early Warning Indicators for Population-Based Monitoring of HIV Drug Resistance in 6 African Countries

Building Capacity for the Assessment of HIV Drug Resistance: Experiences From the PharmAccess African Studies to Evaluate Resistance Network

Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study

Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance—HIV drug resistance in sub-Saharan Africa and the Asia-Pacific

Phase I trial with oral oxihumate in HIV-infected patients

Building Capacity for the Assessment of HIV Drug Resistance: Experiences From the PharmAccess African Studies to Evaluate Resistance Network: The World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: Global, Regional, and Country Progress

Early Warning Indicators for Population-Based Monitoring of HIV Drug Resistance in 6 African Countries: The World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: Global, Regional, and Country Progress

Using e-coins to ensure fair sharing of donor funds amongst HIV healthcare facilities : research article

Suchergebnisse filtern